These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20621456)

  • 1. The EU paediatric regulation: effects on paediatric psychopharmacology in Europe.
    Stoyanova-Beninska VV; Wohlfarth T; Isaac M; Kalverdijk LJ; van den Berg H; Gispen-de Wied C
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):565-70. PubMed ID: 20621456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of the 12th and 14th amendments to the AMG (Medical Preparations Act) on paediatric pharmaceutical research--a survey of the new regulations].
    Kölch M; Lippert HD; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2006 Mar; 34(2):117-26. PubMed ID: 16610597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The new German drug market law AMNOG from a child and adolescent psychiatry perspective].
    Dittmann RW
    Nervenarzt; 2016 Apr; 87(4):367-75. PubMed ID: 26992908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European perspectives on pediatric formulations.
    Breitkreutz J
    Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical issues in psychopharmacology of children and adolescents.
    Koelch M; Schnoor K; Fegert JM
    Curr Opin Psychiatry; 2008 Nov; 21(6):598-605. PubMed ID: 18852568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric psychopharmacology.
    Riddle MA; Kastelic EA; Frosch E
    J Child Psychol Psychiatry; 2001 Jan; 42(1):73-90. PubMed ID: 11205625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EU-regulation on medicinal products for paediatric use: impacts on child and adolescent psychiatry and clinical research with minors.
    Kölch M; Schnoor K; Fegert JM
    Eur Child Adolesc Psychiatry; 2007 Jun; 16(4):229-35. PubMed ID: 17417746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric psychopharmacological research in the post EU regulation 1901/2006 era.
    Schmäl C; Becker K; Berg R; Brünger M; Lehmkuhl G; Oehler KU; Ruppert T; Staudter C; Trott GE; Dittmann RW
    Z Kinder Jugendpsychiatr Psychother; 2014 Nov; 42(6):441-9. PubMed ID: 25335522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory aspects of clinical trials in children.
    Mentzer D
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():203-7; discussion 207-9. PubMed ID: 20799462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are children getting the right drugs?].
    Bratlid D
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3290-2. PubMed ID: 16327857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring in child and adolescent psychiatry.
    Egberts KM; Mehler-Wex C; Gerlach M
    Pharmacopsychiatry; 2011 Sep; 44(6):249-53. PubMed ID: 21959786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives.
    Persico AM; Arango C; Buitelaar JK; Correll CU; Glennon JC; Hoekstra PJ; Moreno C; Vitiello B; Vorstman J; Zuddas A;
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1513-31. PubMed ID: 26166453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell transplantation in children: how to design a new study.
    Corbacioglu S;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacology of pediatric bipolar disorders in children and adolescents.
    Thomas T; Stansifer L; Findling RL
    Pediatr Clin North Am; 2011 Feb; 58(1):173-87, xii. PubMed ID: 21281855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric psychopharmacology: food and drug administration approval through the evidence lens.
    Lorberg B; Robb A; Pavuluri M; Chen DT; Wilens T
    J Am Acad Child Adolesc Psychiatry; 2014 Jul; 53(7):716-9. PubMed ID: 24954819
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
    Mentzer D
    Int J Pharm; 2014 Aug; 469(2):240-3. PubMed ID: 24613178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European paediatric research and children's therapeutic needs. A trial review.
    Pandolfini C; Bonati M
    Acta Paediatr; 2008 Sep; 97(9):1232-7. PubMed ID: 18489618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase IV research by pharmaceutical companies.
    Hakkarainen H; Hattab JR; Venulet J
    Pharmacopsychiatry; 1984 Sep; 17(5):168-75. PubMed ID: 6494246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacology of schizophrenia in children and adolescents.
    Carlisle LL; McClellan J
    Pediatr Clin North Am; 2011 Feb; 58(1):205-18, xii. PubMed ID: 21281857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.